Federal award
KBR WYLE SERVICES, LLC
0290
Contract
Obligated and Ceiling
- Obligated (net)
- $9,029,232.14
- Ceiling (potential value, not spending)
- $29,187,076.00
- Current value
- $29,187,076.00
- Gross positive obligations
- $9,150,455.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of War · sub-agency 9763 · office S0107A
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0290
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 23 · Aug 29, 2013 to May 7, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History23
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 7, 2018 | FY2018 | 1A | C | −$59,843.86 | |
| Dec 12, 2016 | FY2017 | 21 | K | −$61,379.00 | |
| May 23, 2016 | FY2016 | 20 | C | $19,106.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 5, 2016 | FY2016 | 19 | C | $78,508.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 25, 2016 | FY2016 | 18 | C | $197,823.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 22, 2016 | FY2016 | 17 | C | $148,546.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 5, 2016 | FY2016 | 16 | C | $296,700.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 22, 2015 | FY2015 | 15 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 15, 2015 | FY2015 | 14 | C | $212,660.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 11, 2015 | FY2015 | 13 | C | $106,627.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 17, 2015 | FY2015 | 12 | C | $310,595.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 24, 2015 | FY2015 | 11 | C | $1,162,216.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 28, 2015 | FY2015 | 10 | C | $396,662.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 15, 2015 | FY2015 | 9 | C | $200,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 25, 2015 | FY2015 | 8 | C | $224,728.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 9, 2015 | FY2015 | 7 | C | $499,355.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 24, 2014 | FY2015 | 6 | C | $300,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 11, 2014 | FY2014 | 5 | C | $1,942,078.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 24, 2014 | FY2014 | 4 | C | $98,814.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 30, 2013 | FY2013 | 3 | C | $200,869.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 27, 2013 | FY2013 | 2 | C | $1,000,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 24, 2013 | FY2013 | 1 | C | $30,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 29, 2013 | FY2013 | 0 | — | $1,725,168.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.